{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-070584","form_type":"8-K","ticker":"KURA","cik":"0001422143","company_name":"Kura Oncology, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.347632+00:00","generated_at":"2026-06-01T05:31:24.679247+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Kura Oncology stockholders approve 5.5M share increase to equity plan at June 5 annual meeting","bullets":["Stockholders approved Amended 2014 Plan, increasing authorized shares by 5.5M to total 29,827,686 shares.","Troy E. Wilson and Faheem Hasnain elected as Class I directors until 2027 annual meeting.","Ratification of Ernst & Young as auditor for FY2024 approved (69.6M for, 56.7K against).","Advisory vote on executive compensation approved with 61.5M for, 5.4M against.","About 69.8M of 76.2M outstanding shares were represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-070584","json":"https://secwatch.observer/filing/0000950170-24-070584.json","markdown":"https://secwatch.observer/filing/0000950170-24-070584.md","text":"https://secwatch.observer/filing/0000950170-24-070584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024070584/0000950170-24-070584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024070584/kura-20240605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:31:24.679247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}